KeyLemon raised €1.1M in a Series A round in Sep 2013. The company is based in Martigny, Switzerland. Investors in the round: Debiopharm Group, Swisscom Ventures. Data as of 6 Aug 2026.
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
